Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy

Virdi Eye Clinic

Status: Completed

Conditions: Myopia

Treatments: Drug: Bromfenac

Study type: Observational

Funder types: Other

Identifiers

NCT01475877

MAC-02-11

Details and patient eligibility

About

This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.

Enrollment: 20 patients

Sex: All

Ages: 21+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• male or female at least 18 years of age,
• no other ocular studies with 15 days prior to dosing,
• BCVA 20/200 or better,
• return for study visits and follow instructions from investigator and staff,
• self administer test article

Exclusion criteria

• Ocular inflammation,
• hypersensitivity to bromfenac or nepafenac,
• any corneal pathology,
• have had radial keratotomy,
• corneal transplant or corneal refractive surgery in the last two years

Trial design

20 participants in 1 patient group

Nepafenac

Treatment:

Drug: Bromfenac